CONMED Corporation
As of Oct 22, 2026, CONMED is in Stage 2, the uptrend phase, now in week 10 (since Aug 14, 2026). It closed at $49.44, 4.7% below its 52-week high and above its 200-day average, which is rising.
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care
Is CNMD early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
CNMD among Medical Devices45th of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …45 | CNMD | Stage 2 · wk 10 | 56 | +7.9% |
CONMED: quick answers
What stage is CONMED in?
As of Oct 22, 2026, CONMED (CNMD) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 14, 2026 and is in week 10. What the four stages mean
Is CONMED in an uptrend?
Yes. CONMED is in a Stage 2 uptrend. It trades 19.7% above its 200-day average, which is rising.
How far is CONMED from its 52-week high?
CONMED closed at $49.44 on Oct 22, 2026, 4.7% below its 52-week high of $51.86. Its 52-week low is $32.11.
How has CONMED performed over the past year?
As of Oct 22, 2026, CONMED is up 2.2% over the past year and up 22.0% so far in 2026.
Which sector and industry is CONMED in?
CONMED is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solutions comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures; and products to treat diseases of dilation, hemostasis, biliary, stricture management, and infection prevention, as well as ECG electrodes, EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.